Focal Point Pharmaceuticals Overview
- Founded
- 2013
- Status
- Private
- Latest Deal Type
- Early Stage VC
- Latest Deal Amount
- $80K
- Investors
- 1
Focal Point Pharmaceuticals General Information
Description
Developer of pharmaceutical products designed to treat ocular diseases. The company's products are developed with pre-clinical research and lead selection, enabling healthcare practitioners to treat rare diseases, including ocular trauma and other eye diseases.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 40 South Main Street
- Suite 2300
- Memphis, TN 38103
- United States
+1 (484) 000-0000
Focal Point Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 31-Jan-2017 | $80K | 00000 | Completed | Startup | |
| 1. Early Stage VC | 14-Aug-2013 | 00000 | 00000 | Completed | Startup |
Focal Point Pharmaceuticals Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Edward Chaum MD | Co-Founder & Chief Scientific Officer | ||
| Gary Prosterman | Treasurer & Board Member | ||
| Raymond Hage Jr. | President & Board Member |
Focal Point Pharmaceuticals Board Members (3)
| Name | Representing | Role | Since |
|---|---|---|---|
| Gary Prosterman | Focal Point Pharmaceuticals | Treasurer & Board Member | 000 0000 |
| Gary Stevenson | MB Venture Partners | Board Member | 000 0000 |
| Raymond Hage Jr. | Self | President & Board Member | 000 0000 |
Focal Point Pharmaceuticals Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| MB Venture Partners | Venture Capital | Minority | 000 0000 | 000000 0 |